The American biotechnology company Moderna said that its vaccine against coronavirus will protect against new variants of the virus that are spreading in Great Britain.
“Based on data to date, Moderna expects that the immune-induced vaccine from Moderna COVID-19 will protect against the SARS-CoV-2 virus versions recently described in the UK,” the company said in a statement on Wednesday.
He noted that additional tests would be performed in the coming weeks to confirm the efficacy of the vaccine relative to the new variants to confirm this expectation.
“Although we plan to launch tests to confirm vaccine activity against any strain, the wide range of potential neutralizing antibodies provided by the Modern COVID-19 vaccine provides assurance that our vaccine will also be effective in inducing neutralizing antibodies against them,” Moderna added.
They were said to have already tested “a number of previous variants” of the virus that had emerged since the start of the pandemic and found that its vaccine would “remain equally effective”.
The modern vaccine, the second in the U.S. after Pfizer-BioNTech, began distribution after it received emergency approval last Friday from the U.S. Food and Drug Administration.
On Tuesday, U.S. Secretary of Health and Human Services Alex Azar and top infectious disease expert Anthony Fauci received the vaccine from Moderna.
The Anadolu Agency website contains only a part of the news offered to subscribers in the AA News Broadcasting System (HAS), in a concise form. Please contact us for subscription options.